deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT01822795

Lung Volume Reduction Coil Treatment in Emphysema. (STICREVOLENS)

Cost-effectiveness of Lung Volume Reduction Coil Treatment in Emphysema.

Sponsor: CHU de Reims

Conditions Emphysema
Updated 7 times since 2017 Last updated: Apr 29, 2014 Started: Mar 31, 2013 Primary completion: Mar 31, 2015 Completion: Dec 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Emphysema, this trial is ongoing. The trial is conducted by CHU de Reims and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshotActive Not Recruiting~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Jan 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

    Status: Active Not RecruitingUnknown Status

Show 2 earlier versions
  1. Jun 2018 — Jan 2020 [monthly]

    Active Not Recruiting PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CHU de Reims
  • PneumRx, Inc.
Data source: CHU de Reims

For direct contact, visit the study record on ClinicalTrials.gov .